Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 547 results for "fda centre for drug evaluation and re..."

Anika Therapeutics Announces Decision to Proceed with CINGAL P...

You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: Anika Therapeutics Announces Decision to Proceed with CINGAL Premarket Review Through FDA's Center for ... FirstWord Pharma, 2 months ago

3 images for "fda centre for drug evaluation and research"

Reuters UK, 18 hours ago
Bioresearch Online, 2 weeks ago
Reliance Trust, 1 month ago
European Pharmaceutical Review

FDA approves Zepatier for treatment of chronic HCV GT1 and GT4

The US Food and Drug Administration (FDA) has approved Merck's Zepatier (elbasvir and grazoprevir) for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype (GT) 1 or GT4 infection, with or without ribavirin (RBV). Zepatier ...
 European Pharmaceutical Review2 weeks ago FDA approves Eisai's Halaven in liposarcoma  European Pharmaceutical Review2 weeks ago FDA approves Allergan's Botox to treat lower limb spasticity in adults  Pharmaceutical Technology2 weeks ago FDA approves Basaglar, a long-acting insulin treatment  European Pharmaceutical Review1 month ago
Business Standard India

Earnings estimates and target prices cuts for Sun Pharma

A man carrying a gas cylinder walks out of the research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai Sun Pharmaceutical Industry's fortunes on the bourses continue to remain topsy-turvy. Just as the stock was gaining some ...
 Business Standard India1 month ago

FDA Psychopharmacologic Drug Advisory Committee Supports the Effectiveness of Brintellix® (vortioxetine) in Treating Certain Aspects of Cognitive Dysfunction in Major Depressive Disorder (MDD)

- The panel voted 8-2 that substantial evidence has been presented to support a claim of effectiveness for Brintellix for treating certain aspects of cognitive dysfunction in MDD- The panel discussed that cognitive dysfunction in MDD represents an ...
 TickerTech.com1 week ago
[x]  

Cellectar Biosciences and Pierre Fabre Laboratories Announce Oncology Research Collaboration

MADISON, Wis., and CASTRES, France, Dec. 16, 2015 (GLOBE NEWSWIRE) -- Pierre Fabre, the third largest French pharmaceutical company, and Cellectar Biosciences, Inc. ( NASDAQ:CLRB ), an oncology-focused biotechnology company, today announce a ...
 Market Pulse Navigator1 month ago Cellectar Biosciences : and Pierre Fabre Laboratories Announce Oncology Research Collaboration  4 Traders1 month ago
[x]  

2015: The year's biggest Drug Development Technology stories

Researchers at Cardiff University developed a method for improving the delivery of therapeutic molecules to kill cancer cells and cells affected by other diseases, such as tuberculosis. Due to their inability to reach the targeted parts of an ...
 Drug Development Technology1 month ago

FDA Approves New Oral Therapy for ALK-Positive Lung Cancer

The FDA has approved alectinib (Alecensa, Genentech) to treat patients with advanced (metastatic) anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) whose disease has worsened after, or who could not tolerate, treatment ...
 Advance for Nurses1 month ago FDA approves Roche's Alecensa for ALK-positive NSCLC  European Pharmaceutical Review2 months ago
Pharmafile

Dispelling four myths about the FDA

Does the U.S. Food and Drug Administration control the price of drugs? Do other countries approve drugs faster than the United States? Can the FDA tell doctors how to prescribe drugs? There is a lot of misinformation about exactly what the FDA does ...
 PM 3601 month ago FDA approves AstraZeneca's gout drug Zurampic  Pharmafile1 month ago FDA approves Zurampic for patients with gout  European Pharmaceutical Review1 month ago
European Pharmaceutical Review

FDA approves Uptravi for pulmonary arterial hypertension

The US Food and Drug Administration (FDA) has approved Actelion's Uptravi (selexipag) for the treatment of pulmonary arterial hypertension. Uptravi belongs to a class of drugs called oral IP prostacyclin receptor agonists. The drug acts by relaxing ...
 European Pharmaceutical Review1 month ago The New England Journal of Medicine publishes "Selexipag for the treatment of pulmonary arterial hypertension"  EuroInvestor1 month ago GNW-News: The New England Journal of Medicine publishes "Selexipag for the treatment of pulmonary arterial hypertension" (english)  Pharmacy Choice1 month ago
[x]  
AlterNet.org

The Truth About E-Cigarettes: Are They Really Safer Than Real Ones?

Researchers evaluated the content of 51 e-cigarettes, specifically focusing on flavors that would be appealing to children and adolescents. Since the introduction of e-cigarettes in 2004, their use has grown dramatically, with a number of ...
 AlterNet.org1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less